Few Treatment Options Remain for GonorrheaApr 13, 2007 - 2:35:55 AM , Reviewed by: Dr. Venkat Yelamanchili
New treatment recommendations are critical if we are to continue to see progress in controlling gonorrhea
Gonorrhea is the second most commonly reported infectious disease in the United States after chlamydia. In 2005, 339,593 cases were reported nationwide, although experts believe the actual number of cases may be twice that. Following a substantial decline in national gonorrhea rates from 1975 to 1997, overall rates appear to have leveled off in recent years.
The Centers for Disease Control and Prevention (CDC) no longer recommends antibiotics known as fluoroquinolones (ciprofloxacin, ofloxacin, and levofloxacin) as a treatment for gonorrhea in the United States. This limits the options available to treat gonorrhea, one of the most common sexually transmitted diseases in the United States.
Resistant gonorrhea spreading in US